Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 2 minute read Pharma Industry News Protagonist Therapeutics secures $22m to advance IBD treatment Protagonist Therapeutics, a clinical-stage biopharmaceutical company specializing in the discovery and development of novel peptide-based drugs, has successfully… bypharmanewsdailyAugust 6, 2018